WHAT IS MONOVISC?
MONOVISC is the new generation single injection viscosupplement with 4ml of highly purified, non-animal derived Hyaluronic Acid (HA). MONOVISC is also FDA & EU Approved.
Unique Features of MONOVISC are
- High dose of Optimum Molecular Weight (88mg in 1 injection)
- Application of Light Cross-Linked technology
- Optimal Viscosity profile.
What is the efficacy for MONOVISC?
Monovisc provides pain relief as early as 2 weeks with faster and longer lasting pain relief up to 24 weeks compared to other competitor brand in the market.
What are the side effects?
- Small & Transient Pain, warmth and slight swelling immediately after injection. (Note : ComfortPlus Hot/Cold Pack is provided to help ease the discomfort after injection.)
- In clinical studies, the most commonly reported adverse events for MONOVISC were arthralgia, joint swelling and injection site pain.